The health and economic burden of physical inactivity is well documented. A wide range of primary care and community-based interventions are available to increase physical activity. It is important to identify which components of these interventions provide the best value for money.
INTRODUCTION
The prevalence of physical inactivity remains high in developed and developing countries. 1 Not only does physical inactivity contribute to increased prevalence of chronic conditions such as cardiovascular disease, obesity, type 2 diabetes, osteoporosis, colon cancers, depression, and fall-related injuries, but it also contributes to between 1.5% and 3.0% of direct healthcare costs in developed countries. 1 A wide range of interventions have been shown to increase physical activity. 2 However, it is essential to identify which components provide the best value for money.
Physical activity counselling in primary health care has been recommended. 3 In some countries at least 80% of the population visit primary health care annually, 4, 5 making this an ideal setting for intervening to increase physical activity. Furthermore, patients expect to receive health-related messages in this
Results
Thirteen studies fulfilled the inclusion criteria. Eight studies were of good or excellent quality. Interventions, study populations, and study designs were heterogeneous, making comparisons difficult. The cost to move one person to the 'active' category at 12 months was estimated for four interventions ranging from €331 to €3673. The cost-utility was estimated in nine studies, and varied from €348 to €86 877 per QALY.
Conclusion
Most interventions to increase physical activity were cost-effective, especially where direct supervision or instruction was not required. Walking, exercise groups, or brief exercise advice on prescription delivered in person, or by phone or mail appeared to be more costeffective than supervised gym-based exercise classes or instructor-led walking programmes. Many physical activity interventions had similar cost-utility estimates to funded pharmaceutical interventions and should be considered for funding at a similar level.
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context and may therefore be more receptive to brief advice or referral to community-based interventions. It is still not known if physical activity interventions in this context are cost-effective, or which types of intervention are the most cost-effective. Nor is it known how cost-effective these interventions are when compared with other interventions in primary health care, such as pharmaceutical interventions that are also aimed at reducing chronic disease.
Physical activity interventions based in primary health care, such as exercise on prescription, have been shown to be effective [6] [7] [8] [9] and cost-effective, 10, 11 with a cost-utility ratio comparable to many currently-funded pharmaceutical therapies. A systematic review of the cost-effectiveness of physical activity interventions within primary health care was completed in 2002, in which eight studies were identified, published between 1996 and 2002. 12 The review found that there was a trend towards favourable cost-effectiveness of physical activity promotion through primary health care but there were few trials available of mixed study quality. The cost-effectiveness of community-based physical activity promotion in general was assessed by another systematic review which also showed favourable results, but included modelling studies and evaluations of workplace or infrastructural innovations in the community, as well as individualbased interventions to promote physical activity. 13 The current systematic review assesses the evidence for cost-effectiveness of physical activity interventions in the community, particularly in primary care, and only those based on randomised controlled trials conducted since the previous review of primary care evidence in 2002.
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METHOD
Search strategy
A literature search was carried out using eight healthrelated electronic databases (Table 1) .
Systematic Review
e126
Selection process
To be included in the systematic review, studies had to be economic analyses of lifestyle interventions that included physical activity advice and/or programmes for adults, and were based in either primary care or the community, published in English since 2002, used general study populations or those with disease states known to be improved by physical activity, and had a follow-up period of at least 6 months. Only those cost analyses that had been conducted in association with randomised controlled trials of physical activity interventions were included. The review excluded studies that were based in the workplace, used economic modelling rather than actual costs, were economic analyses based on case-studies, surveys, non-experimental studies, or theoretical scenarios, involved unique disease-state populations (for example cardiac rehabilitation patients), or did not include either cost per physical activity measure or cost per quality-adjusted life-year (QALY) as outcomes.
Data extraction and analysis
Data extraction was undertaken by the primary author and verified by a second author. Type of
How this fits in
Community-and primary healthcare-based physical activity interventions have been shown to be effective in increasing population physical activity levels. The cost-effectiveness of these interventions varies and it is still not known if physical activity interventions in this context are cost-effective, which types of intervention are the most cost-effective, and how these interventions compare with others delivered in primary health care, such as pharmaceutical interventions. This study found that many interventions to increase physical activity were within the generally accepted range of cost-effectiveness, especially where direct supervision or instruction was not required. Based on the higher-quality studies, it is possible to deliver a physical activity intervention for between €1120 and €15 860 per quality-adjusted life-year gained, which is more cost-effective than many other currently-funded pharmaceutical interventions. Based on the extent to which each study met Drummond's criteria, a rating of 'poor', 'fair', 'good', or 'excellent' was assigned and is listed in the first column of Table 3 .
To compare the economic results of individual studies, all costs were converted to Euros (€), 15 using economic analysis and perspective, intervention and comparison, participants, follow-up duration, and outcome were recorded from each study that fulfilled the inclusion criteria. Studies were assessed for methodological quality using Drummond's checklist for assessing economic evaluations ( 
Systematic Review
annual average exchange rates. This method has been used previously. 13 Costs have then been converted to the reference quarter of June 2008 using consumer price index (CPI) adjustments from each 
RESULTS
Studies identified
The literature search identified 696 publications, from which 38 were assessed in detail. Of those, 13 studies met the selection criteria and were included in this review (Figure 1 ). Studies were excluded for the following reasons: eight studies did not use outcome measures that were either cost per QALY gained or a physical activity measure; two studies targeted a very specific population for secondary prevention (for example, cardiac rehabilitation patients); two studies were set in the workplace; four studies included a combined intervention (physical activity plus a nutrition intervention, or physical activity plus a psychological intervention) where the impact of the physical activity intervention could not be isolated; and four analyses were based on inadequate trials, due to short follow-up (3 months), high attrition (45%), insufficient power due to small sample size (n = 36), or absence of a comparison group. The 13 studies that met the inclusion criteria are described in Table 3 and grouped by targeted population or condition (musculoskeletal conditions, obesity or depression, sedentary adults). The descriptions of the interventions, follow-up and incremental cost-effectiveness ratios for instructor-led and supervised exercise, exercise and nutrition programmes, community walking, and brief counselling with exercise on prescription are also presented in Table 3 . Community walking, exercise and nutrition programmes, and brief counselling with exercise on prescription (Green Prescription) had more favourable cost-effectiveness ratios than instructorled or supervised exercise sessions (Figure 2 ).
DISCUSSION
Summary of main findings
Most interventions to increase physical activity were cost-effective when compared with international thresholds for acceptable value for funded interventions, 28 especially where direct supervision or instruction were not required. Walking, exercise 
QALY = quality-adjusted life-year.
S Garrett, CR Elley, SB Rose, et al e131 groups, or brief exercise advice on prescription delivered in person, or by phone or mail, had a lower cost per QALY compared with supervised gym-based exercise classes or instructor-led walking programmes. Many physical activity interventions had similar estimates of cost-utility to funded pharmaceutical interventions. Costs per QALY gained varied substantially between the studies. The cost of moving one person from 'inactive' to 'active' at 12 months was estimated for four interventions, and ranged from €331 to €3673. Cost-utility was estimated in nine studies and varied from €348 to €86 877 per QALY. Community walking, 21 exercise and nutrition programmes, 25 and brief advice with exercise on prescription (Green Prescription) 10 were the most cost-effective with respect to cost-utility. The Green Prescription, 6 enhanced Green Prescription, 27 and printed material or phone-delivered advice 23 had similar costeffectiveness ratios for moving one sedentary person to an active state.
When considering interventions for specific disease-based populations, the exercise prescription given by the GP and exercise counselling by the practice nurse for people with chronic or recurrent low back pain 20 was more cost-effective (€4577 per QALY) than the water-based exercise intervention for older participants with osteoarthritis of the hip and/or knee (€9160 per QALY). 18 A weekly exercise class for sedentary people aged 65 years and older 24 was more cost-effective (€19 425 per QALY) than both the supervised gym-based exercise classes and the instructor-led walking programme for sedentary 40-74 year olds (€35 665 and €86 877 per QALY). 26 The findings suggest that advice interventions, such as exercise on prescription and some group-based exercise programmes, are more cost-effective than individualised gym-based or instructor-led walking groups.
There is no universal threshold of cost per QALY gained to determine whether an intervention should be funded. However, most of the cost per QALY values from studies reviewed here were below the threshold reported by the National Institute for Health and Clinical Excellence (NICE) (£20 000-30 000), 28 and lower than values reported for many funded pharmaceutical and other interventions for conditions such as diabetes (cholesterol control: €58 882 per QALY gained; intensive glucose control: €32 610 per QALY gained; case management: €41 452 per QALY gained). [29] [30] [31] [32] It should be noted that one study found exercise interventions were effective for functional improvements compared with 'usual care'. 19 However, greater gains in quality-of-life measures were found in the 'usual care' group than in the 'exercise' intervention groups (negative cost per QALY), so the cost per QALY was difficult to interpret. 19 Comparing the annual cost per participant to become active is difficult due to the different definitions and analytical approaches used. Handley et al used the cost to achieve a 10% increase in the proportion of participants achieving recommended moderate or vigorous physical activity levels in a study involving adults with type 2 diabetes. 22 The annual cost to increase activity by 10% for the automated telephone surveillance and nurse care management was estimated to be €551 per participant. In contrast, two studies by Elley et al 11, 27 used a threshold of 5 x 30 minutes of activity per week and found the cost per person to be €957 when predominantly doctor delivered, 11 and €331 when nurse delivered. 27 Most studies followed up participants for only 6-12 months, with only two costeffectiveness studies undertaken on the basis of a 2-year trial. 24, 27 Strengths and limitations of the study A strength of the current review is the inclusion of cost-effectiveness analyses that were based on randomised controlled trials. Accordingly, the quality of evidence included is high. However, estimates of cost-effectiveness are likely to be conservative because not all long-term benefits are accounted for in short-term randomised controlled trials. Modelled economic analyses suggest the cost-effectiveness of physical activity interventions may be even more favourable when long time horizons are taken into account. 33 The variability of outcome measures, interventions, target population groups, costs measured, and health-system variations in cost makes comparison of these cost-effectiveness studies difficult. With different infrastructures, funding models, and cost structures, it is also difficult to make comparisons between different countries. Furthermore, some studies included funder costs only, 17, [21] [22] [23] [24] [25] [26] while others presented societal perspectives that also included costs to the participant. 11, [18] [19] [20] 27 Consequently, there was a wide variation in costs per QALY gained between the studies. For example, the study of Gusi et al, involving a walking programme for older women who were overweight or had moderate depression, had the lowest cost per QALY of €348. 21 By comparison, the intervention with the highest cost per QALY of €86 877 was an instructor-led walking programme (10 weeks, 2-3 times per week) for physically inactive 40-74-year-old adults. 26 Even so, all interventions had cost-utility (cost per QALY) values within the range of pharmaceutical interventions that are currently considered for funding by governmental funding agencies.
Systematic Review
Comparison with existing literature
A previously published systematic review included eight studies involving interventions promoting physical activity, 13 but included workplace and environmental interventions and economic modelling rather than actual costs. The previous review found that interventions directly targeting individual behaviour were able to promote the recommended levels of physical activity at a cost of about €800 per participant shifted to an active category over a 12-month period. Interventions within general practices had the most favourable cost-effectiveness ratios (€106 per participant to reach at least 3300 kJ expended per week); however, the study was based on modelled rather than actual costs. 34 Gordon et al reviewed the cost-effectiveness of a number of lifestyle interventions for smoking cessation, physical activity, diet, and alcohol reduction. 35 The findings for physical activity interventions generally indicated favourable costeffectiveness: less than €55 860 per QALY, and two studies showed net cost savings. 36, 37 Using a lifetime cost-effectiveness analysis from a societal perspective on a simulated cohort, Roux et al examined seven types of community-based physical activity interventions. 33 All of the interventions evaluated were found to be cost-effective, with costs per QALY gained ranging from €9763 to €46 853.
Implications for clinical practice
Due to the variability in study design and differences in outcome variables between the studies reviewed, it is difficult to draw firm conclusions about which types of interventions are most cost-effective. However, it appears that interventions such as 'exercise on prescription' delivered by primary care doctors or nurses, or brief advice delivered by mail-out or telephone are more cost-effective than intensive gym-based or instructor-led interventions. Furthermore, group exercise programmes appear to be more cost-effective than instructor-led walking programmes. Interventions delivered by nurses may be more cost-effective than when delivered by GPs.
Based on the higher-quality studies, it is possible to deliver a physical activity intervention for between €1120 and €15 860 per QALY gained, which is more cost-effective than many other currently-funded pharmaceutical interventions. Therefore, physical activity interventions delivered in primary health care should be considered for funding at similar levels to currently-funded pharmaceutical interventions.
